Skip to main content
Premium Trial:

Request an Annual Quote

New Mutation Implicated in Ovarian Cancer

Premium

British researchers have found that women who carry a mutated copy of the RAD51D gene have a one in 11 chance of developing ovarian cancer, reports Reuters' Kate Kelland. The researchers, who recently published their study in Nature Genetics, compared the DNA of women from 911 families with breast and ovarian cancer to DNA from a control group and found eight "faults" in the RAD51D gene of the cancer patients compared with only one in the control group, Kelland says. Previous studies had already shown that mutated RAD51D is sensitive to PARP inhibitors. The study's senior author tells Kelland that this discovery may lead to the use of PARP inhibitors to treat women with mutated RAD51D ovarian cancer.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.